NCT02646449View on ClinicalTrials.gov

Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Major Depressive DisorderAlcohol Use Disorder
Interventions
DRUG

Mirtazapine

Gelatin capsules mirtazapine 15 mg, 1 capsule every a.m. Medication will be increased by one capsule, to a dose of 2 capsules barring side effects, at Week 2.

DRUG

Placebo

Gelatin capsules Placebo capsules, identical to mirtazapine capsules, 1 capsule every a.m. Medication will be increased by one capsule to 2 capsules at Week 2, barring any side effects.

Trial Locations (1)

15213

Western Psychiatric Institute and Clinic, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT02646449 - Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial | Biotech Hunter | Biotech Hunter